{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:43:03Z","timestamp":1787244183239,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T00:00:00Z","timestamp":1712448000000},"content-version":"am","delay-in-days":311,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012701","name":"Saga University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015377","name":"Nihon Medi-Physics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017346","name":"Boehringer Ingelheim Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017346","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ejphar.2023.175673","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T21:33:07Z","timestamp":1679607187000},"page":"175673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Linagliptin exacerbates heart failure due to energy deficiency via downregulation of glucose utilization and absorption in a mouse model"],"prefix":"10.1016","volume":"948","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7671-6510","authenticated-orcid":false,"given":"Aya","family":"Shiraki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Node","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.175673_bib1","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.metabol.2014.05.009","article-title":"Potential cardioprotective action of GLP-1: from bench to bedside","volume":"63","author":"Aronis","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.ejphar.2023.175673_bib2","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1161\/CIRCULATIONAHA.107.739938","article-title":"Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor\u2013dependent and \u2013independent pathways","volume":"117","author":"Ban","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2023.175673_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000522284","article-title":"The gut in heart failure: current knowledge and novel frontiers","volume":"31","author":"Gallo","year":"2022","journal-title":"Med. Princ. Pract."},{"key":"10.1016\/j.ejphar.2023.175673_bib4","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa1501352","article-title":"Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes","volume":"373","author":"Green","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2023.175673_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijcard.2011.07.056","article-title":"Analysis of liver metabolism in a rat model of heart failure","volume":"161","author":"Kato","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejphar.2023.175673_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev.nutr.28.061807.155518","article-title":"Sugar absorption in the intestine: the role of GLUT2","volume":"28","author":"Kellett","year":"2008","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.ejphar.2023.175673_bib7","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac energy metabolism in heart failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2023.175673_bib8","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1016\/j.numecd.2021.06.002","article-title":"Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: an extensive meta-analysis of randomized controlled trials","volume":"31","author":"Mannucci","year":"2021","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"key":"10.1016\/j.ejphar.2023.175673_bib9","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1016\/j.numecd.2021.06.002","article-title":"Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: an extensive meta-analysis of randomized controlled trials","volume":"31","author":"Mannucci","year":"2021","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"key":"10.1016\/j.ejphar.2023.175673_bib10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2023.175673_bib11","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart--an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2023.175673_bib12","doi-asserted-by":"crossref","first-page":"33789","DOI":"10.1074\/jbc.M602118200","article-title":"Oxidative stress causes heart failure with impaired mitochondrial respiration","volume":"281","author":"Nojiri","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.175673_bib13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jjcc.2016.05.019","article-title":"EGCG, a green tea catechin, attenuates the progression of heart failure induced by the heart\/muscle-specific deletion of MnSOD in mice","volume":"69","author":"Oyama","year":"2017","journal-title":"J. Cardiol."},{"key":"10.1016\/j.ejphar.2023.175673_bib14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.diabet.2016.09.005","article-title":"Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: meta-analysis of placebo-controlled randomized clinical trials","volume":"43","author":"Rehman","year":"2017","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.ejphar.2023.175673_bib15","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/jama.2019.13772","article-title":"Effect of linagliptin vs glimepiride on major adverse cardiovascular outcomes in patients with type 2 diabetes: the CAROLINA randomized clinical trial","volume":"322","author":"Rosenstock","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2023.175673_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/jama.2018.18269","article-title":"Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial","volume":"321","author":"Rosenstock","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2023.175673_bib17","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2023.175673_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101740","article-title":"SOD2 deficiency in cardiomyocytes defines defective mitochondrial bioenergetics as a cause of lethal dilated cardiomyopathy","volume":"37","author":"Sharma","year":"2020","journal-title":"Redox Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2023.175673_bib19","first-page":"S70","article-title":"Model mice for tissue-specific deletion of the manganese superoxide dismutase gene","volume":"10","author":"Shimizu","year":"2010","journal-title":"Geriatr. Gerontol. Int."},{"key":"10.1016\/j.ejphar.2023.175673_bib20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12933-019-0966-2","article-title":"GLP-1 analog liraglutide-induced cardiac dysfunction due to energetic starvation in heart failure with non-diabetic dilated cardiomyopathy","volume":"18","author":"Shiraki","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2023.175673_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175194","article-title":"Empagliflozin improves cardiac mitochondrial function and survival through energy regulation in a murine model of heart failure","volume":"931","author":"Shiraki","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175673_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142243","article-title":"Pharmacological treatment of hyperglycemia in type 2 diabetes","volume":"131","author":"Taylor","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2023.175673_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012673","article-title":"Glucose metabolism in cardiac hypertrophy and heart failure","volume":"8","author":"Tran","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ejphar.2023.175673_bib24","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/eurheartj\/ehw008","article-title":"Intestinal congestion and right ventricular dysfunction: a link with appetite loss, inflammation, and cachexia in chronic heart failure","volume":"37","author":"Valentova","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2023.175673_bib25","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2337\/db07-0136","article-title":"Effects of dipeptidyl peptidase-4 inhibition on gastrointestinal function, meal appearance, and glucose metabolism in type 2 diabetes","volume":"56","author":"Vella","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2023.175673_bib26","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s11897-022-00554-1","article-title":"Targeting myocardial substrate metabolism in the failing heart: ready for prime time?","volume":"19","author":"Yurista","year":"2022","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.ejphar.2023.175673_bib27","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/S0140-6736(14)62225-X","article-title":"Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial","volume":"385","author":"Zannad","year":"2015","journal-title":"Lancet"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992300184X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992300184X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:14:26Z","timestamp":1757978066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992300184X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":27,"alternative-id":["S001429992300184X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175673","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Linagliptin exacerbates heart failure due to energy deficiency via downregulation of glucose utilization and absorption in a mouse model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175673","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"175673"}}